FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves Zydus Lifesciences' generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Candesartan Cilexetil and Hydrochlorothiazide (Candesartan cilexetil and hydrochlorothiazide)

Snippet

ORIG AP for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE)